| Host: |
Rabbit |
| Applications: |
WB |
| Reactivity: |
Human/Mouse/Rat |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-PAN2-PAN3 deadenylation complex catalytic subunit PAN2-specific ribonuclease-nuclease deadenylation complex subunit 2 is suitable for use in Western Blot research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
| Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Concentration: |
1 mg/mL |
| Dilution Range: |
WB 1:500-2000 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
PAN2 |
| Gene ID: |
9924 |
| Uniprot ID: |
PAN2_HUMAN |
| Specificity: |
This antibody detects endogenous levels of PAN2 at Human, Mouse, Rat |
| Immunogen: |
Synthesized peptide derived from human PAN2 |
| Protein Name | Pan2-Pan3 Deadenylation Complex Catalytic Subunit Pan2Inactive Ubiquitin Carboxyl-Terminal Hydrolase 52Pab1p-Dependent Poly(A-Specific RibonucleasePoly(A-Nuclease Deadenylation Complex Subunit 2Pan Deadenylation Complex Subunit 2 |
| Database Links | Reactome: R-HSA-429947 |
| Cellular Localisation | CytoplasmP-BodyNucleusShuttles Between Nucleus And Cytoplasm |
| Alternative Antibody Names | Anti-Pan2-Pan3 Deadenylation Complex Catalytic Subunit Pan2 antibodyAnti-Inactive Ubiquitin Carboxyl-Terminal Hydrolase 52 antibodyAnti-Pab1p-Dependent Poly(A-Specific Ribonuclease antibodyAnti-Poly(A-Nuclease Deadenylation Complex Subunit 2 antibodyAnti-Pan Deadenylation Complex Subunit 2 antibodyAnti-PAN2 antibodyAnti-KIAA0710 antibodyAnti-USP52 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
